Paid attendees save $299 off the price of PharmAsia News!
Find out more!

While China’s booming economy provides significant commercial opportunities for the life sciences industry, it can also foster an environment of corruption. Authorities in both China and the U.S. have made anti-corruption a priority, cracking down on once common business practices. It's essential for any life sciences executive doing business in China to understand China’s anti-corruption laws and the U.S. Foreign Corrupt Practices Act – and to act now to protect you and your company.

FCPA cases filed by the U.S. Department of Justice and the U.S. Securities and Exchange Commission have escalated during the past few years. These enforcement actions have been marked by record corporate fines and penalties, the imposition of independent monitors, and a willingness by U.S. prosecutors to pursue enforcement against foreign-based companies that violate the FCPA. In China, Premiere Wen Jiabao held a special cabinet meeting in March where the sole item on the agenda was anti-corruption work by the State Council. And it’s not just talk – last year China's Ministry of Health uncovered more than 1,000 commercial bribery cases related to the purchase and distribution of pharmaceuticals, medical equipment and medical services.

What are the relevant anti-bribery laws of both the U.S. and China? What are the most significant corruption risks faced by life sciences companies doing business in the emerging Chinese market? Learn what you must do today to best reduce the risk of corruption violations in China.

Join PharmAsia News and Sidley Austin LLP for a thought-provoking analysis – live from Shanghai and Washington, DC. Grab your team, a conference room at your office, a phone and a computer with web access (that last one's optional). No travel required.

Back to top

Walk away with valuable answers to the following questions:

• How does the FCPA apply to life sciences companies doing business in China?
• What China anti-bribery laws and regulations are of particular significance to the life sciences industry?
• Where are the high-risk areas for corruption in the Chinese pharmaceutical and medical device markets?
• What sanctions are imposed for violations of China’s anti-bribery laws?
• How can you reduce the risk of FCPA and Chinese anti-bribery violations for you and your company?

…and much more!

Back to top

This webinar is aimed at executives in pharmaceutical, biotechnology and medical device companies, including:

• CEOs, senior management and managers of foreign subsidiaries
• Corporate counsel
• Regulatory affairs officials
• Compliance officers and internal auditors
• Business development executives
• Sales and marketing teams
• Company officials traveling to China for business meetings, conferences or related activities

Back to top

Back to top

What does registration get me?

• One (1) phone line, for you alone, or around which to gather your team(s). Toll-free in the U.S. only.
• One (1) password to a website on which you'll be taken through the presenter's slides as they speak to them.
• An interactive Q&A round with speakers: Type your questions on the website during the presentation, for the speakers to address afterward.
• Online access to the audio and slides of the entire event if you can't attend the webinar live, and still want to hear the content.
• The insight you've come to expect and respect from Windhover and our guest speakers.

What are the unique benefits of a webinar?

• Convenience – and lower cost.Your entire team can listen in one room. No travel required!
• A team approach. You've often wanted to have everyone on your team getting the same knowledge and insight you derive from physical conferences. Now you can.
• Interactivity.You're remote, but not removed. Our webinars let you ask the important, burning, controversial questions of our speakers that you'd be able to pose at a physical conference.
• Flexibility. Want to be able to review what you learn? No problem ... just register for the live webinar PLUS a digital copy of the entire event to listen to at your convenience. Interested in the topic but have a scheduling conflict? Don't worry — the recording is available for purchase at any time!

Back to top

Register for the live webinar, the live webinar + CD recording or CD recording only!*

• Register online: Click here for the live webinar
• Register online: Click here for the live webinar PLUS recording
• Buy the recording: Click here for just the recorded webinar
• Register by email: fdcwindhover.custcare@elsevier.com
• Register by phone: 1 (908) 547-2159
• Bill me later:

Registration Form Anti-Bribery Compliance in China – Avoiding the Pitfalls FCPA & China Anti-Bribery Law
Please tell us:
Salutation:	--None-- Mr. Ms. Mrs. Dr. Prof.
First Name :
Last Name:
Title:
Company:
Address :
City :
State/Province:
Zip :
Phone :
Email:
For more information please contact our Customer Service Department at: Phone: 1 (908) 547-2159 Fax: 1 (908) 547-2165 e-mail: fdcwindhover.custcare@elsevier.com

*To subscribe to PharmAsia News and save $299 as a registered attendee of this webinar, please mention promotion code PND806 and contact FDC-Windhover Customer Care at:

• Tel: 1 (908) 547-2159
• Fax: 1 (908) 547-2165
• E-mail: fdcwindhover.custcare@elsevier.com

Back to top